JP2001354664A - Method for producing thiazolidinedione derivative - Google Patents

Method for producing thiazolidinedione derivative

Info

Publication number
JP2001354664A
JP2001354664A JP2000177117A JP2000177117A JP2001354664A JP 2001354664 A JP2001354664 A JP 2001354664A JP 2000177117 A JP2000177117 A JP 2000177117A JP 2000177117 A JP2000177117 A JP 2000177117A JP 2001354664 A JP2001354664 A JP 2001354664A
Authority
JP
Japan
Prior art keywords
general formula
producing
derivative
thiazolidinedione derivative
thiazolidinedione
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2000177117A
Other languages
Japanese (ja)
Inventor
Michiro Onoda
道郎 大野田
Yasumasa Iwai
靖賢 岩井
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kyorin Pharmaceutical Co Ltd
Original Assignee
Kyorin Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyorin Pharmaceutical Co Ltd filed Critical Kyorin Pharmaceutical Co Ltd
Priority to JP2000177117A priority Critical patent/JP2001354664A/en
Publication of JP2001354664A publication Critical patent/JP2001354664A/en
Pending legal-status Critical Current

Links

Abstract

PROBLEM TO BE SOLVED: To provide a method for producing a thiazolidinedione derivative. which is a synthetic intermediate for N-benzyldioxythiazolidinylbenzamide derivatives useful as a hypoglycemic agent. SOLUTION: This method for producing a thiazolidinedione derivative represented by general formula (2), wherein R1 and R2 are each same or different and denote each hydrogen or a lower alkyl group is characterized by reacting a compound represented by general formula (1), wherein R1 and R2 are each as described above; and X denotes a leaving group with thiazolidine-2,4- dione in the presence of a base.

Description

【発明の詳細な説明】DETAILED DESCRIPTION OF THE INVENTION

【0001】[0001]

【発明の属する技術分野】本発明は血糖降下剤及びイン
スリン感受性増強剤として有用なN−ベンジルジオキソ
チアゾリジニルベンズアミド誘導体の合成中間体であ
る、一般式(2) (式中、R及びRは同一又は異なって水素又は低級
アルキル基を表す。)で表されるチアゾリジンジオン誘
導体の製造方法に関する。
The present invention relates to a compound of the general formula (2), which is an intermediate for the synthesis of N-benzyldioxothiazolidinylbenzamide derivatives useful as hypoglycemic agents and insulin sensitivity enhancers. (Wherein, R 1 and R 2 are the same or different and each represent hydrogen or a lower alkyl group.) A method for producing a thiazolidinedione derivative represented by the formula:

【0002】[0002]

【従来の技術】5−ベンジルチアゾリジンジオン誘導体
の合成方法としては、ベンズアルデヒド誘導体とチアゾ
リジンジオンとの縮合により得られる5−ベンジリデン
チアゾリジンジオン誘導体を接触還元(特開平8−10
4688)、あるいは金属水素化物により還元する方法
(特表平7−502530)が公知である。
2. Description of the Related Art As a method for synthesizing a 5-benzylthiazolidinedione derivative, a 5-benzylidenethiazolidinedione derivative obtained by condensation of a benzaldehyde derivative and a thiazolidinedione is catalytically reduced (Japanese Patent Application Laid-Open No. H08-1010).
4688) or a method of reducing with a metal hydride (Japanese Patent Application Laid-Open No. 7-502530).

【0003】しかし、5−ベンジルチアゾリジンジオン
誘導体を工業的スケールで製造する場合、接触還元で
は、高圧水素気流下、大量の触媒を必要とするので、作
業に危険を伴う恐れがあった。また、金属水素化物によ
る還元では、反応条件の設定が難しく、純度、収率等に
再現性に欠けることがあった。
However, when a 5-benzylthiazolidinedione derivative is produced on an industrial scale, the catalytic reduction requires a large amount of a catalyst under a high-pressure hydrogen stream, which may be dangerous. Further, in the reduction with a metal hydride, it is difficult to set the reaction conditions, and the reproducibility of the purity, yield, and the like may be lacking.

【0004】[0004]

【課題を解決するための手段】本発明者らは、N−ベン
ジルジオキソチアゾリジニルベンズアミド誘導体の合成
中間体である5−ベンジルチアゾリジンジオン誘導体の
製造方法に関して鋭意研究を重ねた結果、一般式(1) (式中、R及びRは同一又は異なって水素又は低級
アルキル基を表し、Xは脱離基を表す。)で表される化
合物を、塩基の存在下チアゾリジン−2,4−ジオンと
反応させることにより、一般式(2) (式中、R及びRは同一又は異なって水素又は低級
アルキル基を表す。)が得られることを見いだし、本発
明を完成させたものである。
Means for Solving the Problems The present inventors have conducted intensive studies on a method for producing a 5-benzylthiazolidinedione derivative which is an intermediate for synthesizing an N-benzyldioxothiazolidinylbenzamide derivative. Equation (1) (Wherein, R 1 and R 2 are the same or different and each represent hydrogen or a lower alkyl group, and X represents a leaving group). The compound represented by the formula (I) is reacted with thiazolidine-2,4-dione in the presence of a base. By reacting, the general formula (2) (Wherein R 1 and R 2 are the same or different and represent hydrogen or a lower alkyl group), and the present invention has been completed.

【0005】本発明の関連するチアゾリジンジオン環の
アルキル化についてはいくつかの例が知られている(特
開平1−272573、 Synthesis 31
0,1971.等)が、カルボン酸誘導体を置換基とす
るアラルキル基によるアルキル化は今までに知られてい
なかった。
Several examples of the alkylation of the thiazolidinedione ring of the present invention are known (JP-A-1-272573, Synthesis 31).
0, 1971 . Etc.), but alkylation with an aralkyl group having a carboxylic acid derivative as a substituent has not been known so far.

【0006】一般式(1)で表される化合物は公知(特
開昭48−19539、Bull.Soc.Chim.
Fr.,1969(5),1698.)であるか、また
は公知の方法によって合成することができる。
The compound represented by the general formula (1) is known (JP-A-48-19539, Bull. Soc. Chim.
Fr. , 1969 (5), 1698. ) Or can be synthesized by known methods.

【0007】ここで低級アルキル基とはメチル、エチ
ル、プロピルなど炭素数1〜4の直鎖状もしくは分枝状
のアルキル基を示し、望ましくはメチル基であり、脱離
基とはハロゲン、スルフォニルオキシ基を示し、望まし
くはハロゲンである。
Here, the lower alkyl group is a linear or branched alkyl group having 1 to 4 carbon atoms such as methyl, ethyl and propyl, and is preferably a methyl group, and the leaving group is halogen, sulfonyl. It represents an oxy group and is preferably halogen.

【0008】尚一般式(1)で表される安息香酸誘導体
中、一般式(2)で表されるチアゾリジンジオン誘導体の
合成出発物質として特に有用な5−ヨードメチル−2−
メトキシ安息香酸メチルは文献未記載の新規化合物であ
る。
[0008] Among the benzoic acid derivatives represented by the general formula (1), 5-iodomethyl-2- useful especially as a synthesis starting material for the thiazolidinedione derivative represented by the general formula (2).
Methyl methoxybenzoate is a novel compound not described in the literature.

【0009】一般式(1)の化合物によるチアゾリジン
−2,4-ジオンのアルキル化は、テトラヒドロフラン
のような反応に不活性な溶媒中において、n−ブチルリ
チウム、sec-ブチルリチウム、ナトリウムアミドなどの
塩基の存在下、−78℃から溶媒の沸点間の温度範囲で
行われる。通常、反応終了後、過剰の塩基を水で分解
し、酸性とすれば、一般式(2)の目的化合物を容易に
得ることができる。
Alkylation of thiazolidine-2,4-dione with the compound of the general formula (1) is carried out in a solvent inert to a reaction such as tetrahydrofuran, such as n-butyllithium, sec-butyllithium or sodium amide. It is carried out in the presence of a base in a temperature range between -78 ° C and the boiling point of the solvent. Usually, after completion of the reaction, the target compound of the general formula (2) can be easily obtained by decomposing the excess base with water to make it acidic.

【0010】従来、一般式(2)の化合物が、ベンズア
ルデヒド誘導体とチアゾリジンジオンとの縮合により得
られる5−ベンジリデンチアゾリジンジオン誘導体を接
触還元して製造されていた(特開平9−048771)
のに対し、本発明の方法によれば、原料化合物である一
般式(1)の化合物はベンズアルデヒド誘導体に比べて
安価に入手することができ、また、縮合後に還元工程も
必要としないことから、大幅に工程数を減らすことがで
きるので、工業的に有利な方法を提供されることが本発
明の特徴である。
Heretofore, the compound of the general formula (2) has been produced by catalytic reduction of a 5-benzylidenethiazolidinedione derivative obtained by condensation of a benzaldehyde derivative with a thiazolidinedione (JP-A-9-048771).
On the other hand, according to the method of the present invention, the compound of the general formula (1), which is the starting compound, can be obtained at a lower cost than the benzaldehyde derivative, and does not require a reduction step after the condensation. It is a feature of the present invention that an industrially advantageous method is provided because the number of steps can be greatly reduced.

【0011】[0011]

【実施例】以下に実施例を示して本発明を更に詳細に説
明するが、本発明はこれら実施例によって何らの制限を
受けるものでは無い。
EXAMPLES The present invention will be described in more detail with reference to the following Examples, which should not be construed as limiting the present invention.

【0012】<実施例1> 5−ヨードメチル−2−メ
トキシ安息香酸メチル ヨー化ナトリウム16.4g(109.4mmol)のアセトン
100mLの溶液に、氷冷攪拌下、5−クロロメチル−2
−メトキシ安息香酸メチル20.0g(99.7mmol)のア
セトン25mLの溶液を添加した。室温にて14時間攪拌後、
不溶物を濾別し溶媒を留去した。残留物を酢酸エチル15
0mLに溶解し、水100mLにて洗浄した。硫酸マグネシウム
にて乾燥後、溶媒留去し、褐色晶として表題化合物2
4.5g(80.2%)を得た。1 H-NMR(CDCl3, 60MHz) δ:3.90(6H,s),4.47(2H,s),6.90
(1H,d,J=8.0Hz),7.48(1H,dd,J=2.0,8.0Hz),7.82(1H,d,J
=2.0Hz). IR(KBr):1264,1298,1698cm-1 .
<Example 1>5-iodomethyl-2-me
Methyl oxybenzoate  16.4 g (109.4 mmol) of sodium iodide in acetone
5-Chloromethyl-2 was added to a 100 mL solution under ice-cooling and stirring.
Of methyl 2-methoxybenzoate (20.0 g, 99.7 mmol)
Seton 25 mL of solution was added. After stirring at room temperature for 14 hours,
The insolubles were removed by filtration and the solvent was distilled off. The residue was ethyl acetate 15
It was dissolved in 0 mL and washed with 100 mL of water. Magnesium sulfate
After drying over, the solvent was distilled off to give the title compound 2 as brown crystals.
4.5 g (80.2%) were obtained.1 H-NMR (CDClThree, 60MHz) δ: 3.90 (6H, s), 4.47 (2H, s), 6.90
(1H, d, J = 8.0Hz), 7.48 (1H, dd, J = 2.0,8.0Hz), 7.82 (1H, d, J
= 2.0Hz) .IR (KBr): 1264,1298,1698cm-1 .

【0013】<実施例2> 5−(2,4−ジオキソチ
アゾリジン−5−イル)メチル−2−メトキシ安息香酸
メチル チアゾリジン−2,5−ジオン250mg(2.13mmo
l)を無水テトラヒドロフラン10mLに溶解し、−78
℃にて1.47mol/Lのn-ブチルリチウム溶液2.9mL
(4.26mmol)を加え、室温で30分攪拌した。反応液
を氷冷後、5−ヨードメチル−2−メトキシ安息香酸メ
チル650mg(2.12mmol)の無水テトラヒドロフラン
溶液10mLを加えた。その後50℃にて2時間20分攪拌し
た。反応終了後、0.6mol/Lの塩酸10mLを加え、塩
化メチレンにて抽出した(10mL×2)。有機層を無水硫
酸マグネシウムで乾燥後、濃縮した。残留物をシリカゲ
ルカラムクロマト(ヘキサン:酢酸エチル=3:2)を
用いて精製し、表題化合物310mg(49%)を得た。
m.p. 150−152℃。
<Embodiment 2>5- (2,4-dioxochi)
Azolidine-5-yl) methyl-2-methoxybenzoic acid
Methyl  Thiazolidine-2,5-dione 250 mg (2.13 mmol
l) was dissolved in 10 mL of anhydrous tetrahydrofuran, and
2.9 mL of 1.47 mol / L n-butyllithium solution at ℃
(4.26 mmol) was added and stirred at room temperature for 30 minutes. Reaction liquid
After cooling with ice, 5-iodomethyl-2-methoxybenzoic acid
650 mg (2.12 mmol) of tyl in anhydrous tetrahydrofuran
10 mL of the solution was added. Then stir at 50 ° C for 2 hours and 20 minutes
Was. After completion of the reaction, 10 mL of 0.6 mol / L hydrochloric acid was added, and salt was added.
Extracted with methylene chloride (10 mL × 2). Organic layer anhydrous sulfur
After drying over magnesium acid, it was concentrated. Silica gel residue
Column chromatography (hexane: ethyl acetate = 3: 2)
To give 310 mg (49%) of the title compound.
m. p. 150-152 ° C.

【0014】[0014]

【発明の効果】本発明によって提供されるチアゾリジン
ジオン誘導体の製造方法は、従来、ベンズアルデヒド誘
導体とチアゾリジンジオンとの縮合により得られる5−
ベンジリデンチアゾリジンジオン誘導体を接触還元して
製造されていたのに対し、より安価なハロゲノメチルベ
ンゼン誘導体を用い、製造中に還元工程も必要としない
ことから、大幅に工程数を減らすことができ、工業的に
有利な方法を提供するものである。
According to the process for producing a thiazolidinedione derivative provided by the present invention, a 5-thiazolidinedione derivative obtained by condensing a benzaldehyde derivative with a thiazolidinedione can be used.
Although the benzylidene thiazolidinedione derivative was produced by catalytic reduction, a less expensive halogenomethylbenzene derivative was used, and no reduction step was required during production. It provides a method which is economically advantageous.

Claims (4)

【特許請求の範囲】[Claims] 【請求項1】 一般式(1) (式中、R及びRは同一又は異なって水素又は低級
アルキル基を表し、Xは脱離基を表す。)で表される化
合物を塩基の存在下チアゾリジン−2,4−ジオンと反
応させることを特徴とする一般式(2) (式中、R及びRは前述の通り。)で表されるチア
ゾリジンジオン誘導体の製造方法。
1. General formula (1) (Wherein R 1 and R 2 are the same or different and each represent hydrogen or a lower alkyl group, and X represents a leaving group) in the presence of a base with a thiazolidine-2,4-dione General formula (2) (In the formula, R 1 and R 2 are as described above.) A method for producing a thiazolidinedione derivative represented by the formula:
【請求項2】 R及びRがメチル、Xがハロゲンで
あり、塩基がn−ブチルリチウムである請求項1記載の
チアゾリジンジオン誘導体の製造方法。
2. The method for producing a thiazolidinedione derivative according to claim 1, wherein R 1 and R 2 are methyl, X is halogen, and the base is n-butyllithium.
【請求項3】 請求項1または2記載のチアゾリジオン
誘導体の製造方法に使用される一般式(1)で表される
安息香酸誘導体。
3. A benzoic acid derivative represented by the general formula (1) used in the method for producing a thiazolidione derivative according to claim 1 or 2.
【請求項4】 5−ヨードメチル−2−メトキシ安息香
酸メチルであることを特徴とする請求項3記載の安息香
酸誘導体。
4. The benzoic acid derivative according to claim 3, which is methyl 5-iodomethyl-2-methoxybenzoate.
JP2000177117A 2000-06-13 2000-06-13 Method for producing thiazolidinedione derivative Pending JP2001354664A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2000177117A JP2001354664A (en) 2000-06-13 2000-06-13 Method for producing thiazolidinedione derivative

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2000177117A JP2001354664A (en) 2000-06-13 2000-06-13 Method for producing thiazolidinedione derivative

Publications (1)

Publication Number Publication Date
JP2001354664A true JP2001354664A (en) 2001-12-25

Family

ID=18678758

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000177117A Pending JP2001354664A (en) 2000-06-13 2000-06-13 Method for producing thiazolidinedione derivative

Country Status (1)

Country Link
JP (1) JP2001354664A (en)

Similar Documents

Publication Publication Date Title
US6333415B1 (en) Intermediates and processes for the preparation of optically active octanoic acid derivatives
HUE033534T2 (en) Asymmetric synthesis of a substituted pyrrolidine-2-carboxamide
JP2001233870A (en) 3-(1-hydroxypentylidene)-5-nitro-3h-benzofuran-2-one, method for producing the same and use thereof
JP3831954B2 (en) Process for producing 4-hydroxy-2-pyrrolidone
US5498799A (en) Process for producing optically active 2-norbornanone
JP2001354664A (en) Method for producing thiazolidinedione derivative
JP4029992B2 (en) Production of tartranic acid
JP4899385B2 (en) Method for producing 3-aminomethyloxetane compound
JP4032861B2 (en) Process for producing β-oxonitrile derivative or alkali metal salt thereof
JP3819473B2 (en) 4,4-Bishalomethyl-3-oxoalkanecarboxylic acid derivative and method for producing 3-cyclopropyl-3-oxopropionic acid derivative using the same
JP2579547B2 (en) Preparation of alkoxycarbonyl compounds
JP3275437B2 (en) Process for producing aliphatic β-ketoester
JP3740783B2 (en) Process for producing 4- (2-alkenyl) -2,5-oxazolidinediones
JPH0478638B2 (en)
JP2002512210A (en) Method for producing 2-hydroxyalkylhalophenone
JP3013760B2 (en) Method for producing 4-hydroxy-2-pyrrolidone
JPH09110775A (en) Production of 1-naphthaldehyde
JP4831897B2 (en) Method for producing (2,6-dichloropyridin-4-yl) methanol
EP1777221A1 (en) Process for the preparation of 5-cyanophthalide starting from 5-carboxyphthalide
JP2652248B2 (en) Process for producing alkoxynitrile compounds
JP3013022B2 (en) Method for producing alkyl 3-phthalidylideneacetate
JP3770678B2 (en) Optically active alcohol and its carboxylic acid ester
JP2005263748A (en) Homophenylalanine derivative having reactive diazirine group
JPH0316339B2 (en)
KR20030025394A (en) Preparing Method for N-[3-{3-(1-Piperidinylmethyl)phenoxy}propyl]acetoxyacetamide